MAGELLAN HEALTH, INC. Underwriting AgreementMagellan Health Inc • September 18th, 2017 • Services-hospitals • New York
Magellan Health, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $400,000,000 principal amount of its 4.400% Senior Notes due 2024 (the “Securities”). The Securities will be issued pursuant to an Indenture to be dated as of September 22, 2017 (the “Base Indenture”) by and between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as amended by a First Supplemental Indenture to be dated as of September 22, 2017 (the “Supplemental Indenture” and together with the Base Indenture, the “Indenture”) by and between the Company and the Trustee.
